相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction
Jane A. Cannon et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Therapeutic options of Angiotensin Receptor Neprilysin inhibitors (ARNis) in chronic heart failure with reduced ejection fraction: Beyond RAAS and sympathetic nervous system inhibition
Maurizio Volterrani et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Angiotensin receptor-neprilysin inhibitor (ARNi): Clinical studies on a new class of drugs
Mauro Gori et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure
Milton Packer et al.
LANCET (2017)
The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
Massimo Volpe et al.
CLINICAL SCIENCE (2016)
Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failure
Wesley H. Self et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2016)
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2016)
Developing New Treatments for Heart Failure Focus on the Heart
Mihai Gheorghiade et al.
CIRCULATION-HEART FAILURE (2016)
Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction
Georg Goliasch et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USA
Milton Packer
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial
Orly Vardeny et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens
Michele Senni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
Pardeep S. Jhund et al.
HEART (2016)
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure
Michael R. Zile et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
A Test in Context: Neprilysin Function, Inhibition, and Biomarker
Antoni Bayes-Genis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Plasma levels of intermedin (adrenomedullin-2) in healthy human volunteers and patients with heart failure
David Bell et al.
PEPTIDES (2016)
Endothelin
Anthony P. Davenport et al.
PHARMACOLOGICAL REVIEWS (2016)
Sacubitril/valsartan (LCZ696) for the treatment of heart failure
Mauro Gori et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2016)
Prognostic Significance of Adrenomedullin in Patients With Heart Failure and With Myocardial Infarction
Matthew F. Yuyun et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Contemporary Drug Development in Heart Failure Call for Hemodynamically Neutral Therapies
Muthiah Vaduganathan et al.
CIRCULATION-HEART FAILURE (2015)
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible?
Michele Emdin et al.
CLINICA CHIMICA ACTA (2015)
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
Akshay S. Desai et al.
EUROPEAN HEART JOURNAL (2015)
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF
Pardeep S. Jhund et al.
EUROPEAN HEART JOURNAL (2015)
Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances
John J. V. McMurray
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use
Emilia D'Elia et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction
Sandra Sanders-van Wijk et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
An update of the blockade of the renin angiotensin aldosterone system in clinical practice
Diego F. Marquez et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Soluble Neprilysin Is Predictive of Cardiovascular Death and Heart Failure Hospitalization in Heart Failure Patients
Antoni Bayes-Genis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
Milton Packer et al.
CIRCULATION (2015)
The Renin-Angiotensin-Aldosterone System and Heart Failure
Gabriel Sayer et al.
CARDIOLOGY CLINICS (2014)
Substance P in heart failure: The good and the bad
Heather M. Dehlin et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Endothelial C-type natriuretic peptide maintains vascular homeostasis
Amie J. Moyes et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Meta-analysis of the association between two neprilysin gene polymorphisms and Alzheimer's disease
Guo Xingzhi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Neprilysin Inhibition - A Novel Therapy for Heart Failure
Mariell Jessup
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study
Bryan Williams et al.
BMJ OPEN (2014)
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
Scott D. Solomon et al.
LANCET (2012)
Comparison of Mass Spectrometry and Clinical Assay Measurements of Circulating Fragments of B-Type Natriuretic Peptide in Patients With Chronic Heart Failure
Wayne L. Miller et al.
CIRCULATION-HEART FAILURE (2011)
C-type Natriuretic Peptide (CNP): Cardiovascular Roles and Potential as a Therapeutic Target
Natalie G. Lumsden et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Aβ-Degrading Enzymes: Potential for Treatment of Alzheimer Disease
James Scott Miners et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea Results From the BACH (Biomarkers in Acute Heart Failure) Trial
Alan Maisel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The Regulatory Mechanisms of Cardiac Innervation and Their Critical Roles in Cardiac Performance
Masaki Ieda et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2009)
Detection of Endogenous B-Type Natriuretic Peptide at Very Low Concentrations in Patients With Heart Failure
Eric E. Niederkofler et al.
CIRCULATION-HEART FAILURE (2008)
Pharmacologic targets and prototype therapeutics in the kallikrein-kinin system: Bradykinin receptor agonists or antagonists
J. N. Sharma et al.
THESCIENTIFICWORLDJOURNAL (2006)
Incidence and characteristics of angioedema associated with enalapril
JB Kostis et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH):: randomised, double-blind, placebo-controlled trial
I Anand et al.
LANCET (2004)
Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure
NLM Cruden et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Substance P: Structure, function, and therapeutics
P Datar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Comparison of omapatrilat chronic and enalapril in patients with heart failure - The omapatrilat versus enalapril randomized trial of utility in reducing events (OVERTURE)
M Packer et al.
CIRCULATION (2002)
Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure
MT Rademaker et al.
HYPERTENSION (2002)
Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure - Acute effects of vasodilator therapy
K Stangl et al.
CIRCULATION (2000)
分享论文
